Delivery Order SPE2DB20D2014-SPE2DB24FC81Y
Award Date
8/21/24
Potential Completion Date
9/12/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets. The ceiling value of this award is $3,230.68, and the ultimate completion date is October 31, 2024. The contract is a firm-fixed-price instrument, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will be the prime contractor responsible for delivering this prescription medication to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.95, is for the delivery of Envarsus XR 4 mg tablets over a performance period ending on May 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Envarsus XR 4 mg tablets, a prescription medication, with a ceiling value of $4,845.99 and a completion date of September 25, 2024. The contract is a firm fixed-price, delivery order, with no set-aside designation. Amerisourcebergen is a significant supplier of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablets, a specialized medication. The total ceiling value of the contract is $1,711.95, with a performance period ending on April 17, 2025. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,283.14, is for the delivery of Envarsus XR 4 mg tablets. It is a firm fixed-price contract with a period of performance ending on May 22, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Envarsus XR 4 mg tablets, a pharmaceutical product, and has a ceiling value of $3,230.68 with a period of performance through August 14, 2024. The contract is a firm-fixed-price type with no set-aside designation. As a major pharmaceutical distributor to the federal government, Amerisourcebergen leverages its extensive...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 MG Tablet 100s, a pharmaceutical product. The contract has a firm fixed price of $1,711.95 and a completion date of June 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,711.95 and a completion date of July 2, 2025. It is a firm-fixed-price contract, indicating no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and the place...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a prescription medication. The contract has a ceiling value of $1,711.95 and a period of performance through July 9, 2025. This is a firm-fixed-price delivery order contract without a set-aside designation, indicating open competition....